New Product Development
The Atherosclerosis Market Size is anticipated to attain a valuation of US$ 58,236.4 Million by 2032, growing at a CAGR of 2.8% between 2022 and 2032, from a current value of US$ 44,183.8 Million in 2022. Atherosclerosis is the narrowing of the vein as a result of plaque build-up. Atherosclerosis is a particular kind of arteriosclerosis (stiffening …
Continue reading “Atherosclerosis Market Share, Size, Trends – 2032 | FMI”
The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2577.9 Mn in 2022 and is expected to reach US$ 5313 Mn by 2032. The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing …
Continue reading “Therapeutic Apheresis Market to be USD 5313 Mn by 2032 | Future Market Insights”
The global anti-viral drugs market is expected to be valued at US$ 59,596.8 Million in 2022. The induction of the generic version of antiviral medicines and rising awareness about the availability of various vaccines for viral infections is affecting the growth throughout the forecast period. The overall demand for Anti-Viral Drugs is projected to grow at a CAGR of 3.9% between 2022 and …
Continue reading “Anti-Viral Drugs Market Analysis and Market Studies for 2032 | FMI”
It is anticipated that the global veterinary antibiotics market is worth US$ 10,904.3 million in 2022. The veterinary antibiotics market is expected to expand at a sluggish CAGR of 5.8%, and reach US$ 20,277.5 million by 2032. Over the past few years animal antibiotics have accounted for major share in animal health industry owing to the rising …
Continue reading “Veterinary Antibiotics Market Size & Industry Trends Report for 2032”
The global thoracolumbar stabilization devices market size is projected to be appraised at US$ 2,007.7 million by 2032, up from US$ 1,149.6 million in 2022, advancing at a CAGR of 5.2% from 2022 to 2032.Thoracolumbar is related to the thoracic and lumbar region of the spine. Thoracolumbar stabilization devices are used to reduce or eliminate the instability …
According to a recent study by Future Market Insights (FMI), the global orthopaedic imaging equipment market is expected reach US$ 9.8 Bn in 2021. Sales are expected to increase at a CAGR of around 4.0% over the forecast period (2021-2031). Orthopaedic imaging equipment is the medical imaging equipment used for bone scanning, implants scanning and is utilized for diagnosis purposes. Different imaging technologies …
The global Portable Ultrasound Bladder Scanner Market was valued at US$ 126.3 Mn in 2021 and is expected to reach US$ 191.7 Mn by 2028. As per the findings of a new Future Market Insights (FMI) report, the global portable ultrasound bladder scanner market will thrive on the back of rising adoption of non-invasive diagnostic procedures in urology imaging. …
The Saudi Arabia pharmaceutical market is estimated to be valued at US$ 5,209.5 Mn by 2016 end and is expected to expand at a CAGR of 9.0% over the forecast period (2016–2026). The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, …
In a recent market survey, ESOMAR-certified consulting firm Future Market Insights (FMI) forecasts an impressive growth outlook for the platelet-rich plasma (PRP) market share. The market valuation reached US$ 370.78 Mn in 2021 and is poised to expand at a 6% CAGR through 2031. Growth registered in the platelet-rich plasma market is attributable to increasing applications of PRPs in various procedures …
Continue reading “Platelet Rich Plasma (PRP) Market 6% CAGR through 2031 – Exclusive Report by FMI”
According to a recent study by Future Market Insights (FMI), the global protein A resins market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 536.6 Mn in 2020 to over US$ 1.2 Bn by 2031. This reflects a cumulative CAGR of around 8.1% over the forecast period …